Vinorelbine is an anti-mitotic chemotherapy drug that is used in the treatment of several types of malignancies, including breast cancer and non-small cell lung cancer (NSCLC) . It was initially approved in the USA in 1990's for the treatment of NSCLC .
...
Vinorelbine tartrate is indicated for adults in the treatment of advanced non-small cell lung cancer (NSCLC), as a single therapy or in combination with other chemotherapeutic drugs .
Used in relapsed or refractory Hodgkin lymphoma, in combination with other chemotherapy agents .
...
Research Site, Vinh, Vietnam
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing, China
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Institute of Hematology & Blood Disease Hospital, Tianjin, Tianjin, China
Sanatorio Allende - Cerro-Oncology ( Site 0106), Córdoba, Cordoba, Argentina
Centro de Hematologia e Oncologia ( Site 0203), Joinville, Santa Catarina, Brazil
Americas Centro de Oncologia Integrado ( Site 0202), Rio de Janeiro, Brazil
USC-Norris Comprehensive Cancer Center - Investigational Drug Service IDS, Los Angeles, California, United States
Medstar Georgetown University Hospital, Washington, District of Columbia, United States
Washington Cancer Center, Washington, District of Columbia, United States
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.